Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer

被引：0
|
作者：
Poulie, Christian [1 ]
El Fakiri, Mohamed [2 ]
Ayada, Nawal [2 ]
Gamzov, Teodor [1 ]
Muller, Marius [1 ]
Jensen, Holger [3 ]
Lindegren, Sture [4 ]
Jensen, Andreas [1 ,5 ]
Kjaer, Andreas
Eder, Ann-Christin [2 ]
Eder, Matthias [6 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Tech Univ Denmark, Lyngby, Denmark
[6] Univ Med Ctr, Freiburg, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-017
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [41] Preclinical toxicity study of [211At]PSMA5 in mice and for the FIH clinical trial of targeted alpha therapy against refractory prostate cancer
    Watabe, T.
    Kaneda-Nakashima, K.
    Kadonaga, Y.
    Ooe, K.
    Sampunta, T.
    Yin, X.
    Haba, H.
    Kon, Y.
    Toyoshima, A.
    Cardinale, J.
    Giesel, F. L.
    Fukase, K.
    Tomiyama, N.
    Shirakami, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S345 - S345
  • [42] Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
    Tom A. Bäck
    Karin Jennbacken
    Malin Hagberg Thulin
    Sture Lindegren
    Holger Jensen
    Tove Olafsen
    Paul J. Yazaki
    Stig Palm
    Per Albertsson
    Jan-Erik Damber
    Anna M. Wu
    Karin Welén
    EJNMMI Research, 10
  • [43] Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
    Tadashi Watabe
    Kazuko Kaneda-Nakashima
    Yoshifumi Shirakami
    Yuichiro Kadonaga
    Kazuhiro Ooe
    Yang Wang
    Hiromitsu Haba
    Atsushi Toyoshima
    Jens Cardinale
    Frederik L. Giesel
    Noriyuki Tomiyama
    Koichi Fukase
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 849 - 858
  • [44] Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
    Watabe, Tadashi
    Kaneda-Nakashima, Kazuko
    Shirakami, Yoshifumi
    Kadonaga, Yuichiro
    Ooe, Kazuhiro
    Wang, Yang
    Haba, Hiromitsu
    Toyoshima, Atsushi
    Cardinale, Jens
    Giesel, Frederik L.
    Tomiyama, Noriyuki
    Fukase, Koichi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (03) : 849 - 858
  • [45] Enhancement of astatine (211At) uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha therapy of thyroid cancer
    Watabe, Tadashi
    Kaneda-Nakashima, Kazuko
    Liu, Yuwei
    Shirakami, Yoshifumi
    Ooe, Kazuhiro
    Toyoshima, Atsushi
    Shimosegawa, Eku
    Fukuda, Mitsuhiro
    Shinohara, Atsushi
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [46] PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer
    V. K. Tishchenko
    V. M. Petriev
    O. P. Vlasova
    V. V. Krylov
    P. V. Shegai
    S. A. Ivanov
    A. D. Kaprin
    Physics of Atomic Nuclei, 2022, 85 : 1608 - 1612
  • [47] PSMA-Targeted Theranostic Nanoplex for Prostate Cancer Therapy
    Chen, Zhihang
    Penet, Marie-France
    Nimmagadda, Sridhar
    Li, Cong
    Banerjee, Sangeeta R.
    Winnard, Paul T., Jr.
    Artemov, Dmitri
    Glunde, Kristine
    Pomper, Martin G.
    Bhujwalla, Zaver M.
    ACS NANO, 2012, 6 (09) : 7752 - 7762
  • [48] PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
    Oldan, Jorge D.
    Almaguel, Frankis
    Voter, Andrew F.
    Duran, Alfonso
    Gafita, Andrei
    Pomper, Martin G.
    Hope, Thomas A.
    Rowe, Steven P.
    CANCER JOURNAL, 2024, 30 (03): : 176 - 184
  • [49] PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy of Prostate Cancer
    Tishchenko, V. K.
    Petriev, V. M.
    Vlasova, O. P.
    Krylov, V. V.
    Shegai, P. V.
    Ivanov, S. A.
    Kaprin, A. D.
    PHYSICS OF ATOMIC NUCLEI, 2022, 85 (09) : 1608 - 1612
  • [50] PSMA targeted alpha radiopharmaceutical [211At]PSAt-3 inhibits tumor growth in a preclinical model of prostate cancer
    Hvass, Lars
    Mueller, Marius
    Clausen, Anne
    Herth, Matthias
    Kjaer, Andreas
    CANCER RESEARCH, 2024, 84 (06)
12345